Adverse drug reactions in a cardiology department. Cause of admission or appearance during hospitalisation

Clinical Drug Investigation

Volumn 12, Issue 1, 1996, Pages 46-52

  Vargas, Emilio ^a   Garcia Arenillas, Mar ^a   Laredo, Leonor ^a   Martinez, Maite ^a   Portoles, Antonio ^a   Moreno, Alfonso ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CONTRAST MEDIUM; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; NITRATE;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CLINICAL TRIAL; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH ECONOMICS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RASH; VOMITING;

EID: 0029775115     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199612010-00006     Document Type: Article

References (46)

1. Mulroy R. Iatrogenic disease in general practice: its incidence and effects. BMJ 1973; 2: 407-10
2. Hutchinson TA, Flegel KM, Kramer MS, et al. Frequency, severity and risk factors for adverse drug reactions in adult outpatients: a prospective study. J Chrom Dis 1986; 39: 533-42
3. Spriet A, Spriet C, Larousse C, et al. Methodology and results of a survey of adverse reactions to a drug in private practice. Eur J Clin Pharmacol 1977; 11: 181-92
4. Martys CR. Adverse reactions to drugs in general practice. BMJ 1979; 2: 1194-7
5. Abajo FJ, Frías J, Lopo CR, et al. Las reacciones adversas a medicamentos como un motivo de consulta al servicio de urgencias de un hospital general [in Spanish]. Med Clin Barc 1989; 92: 530-5
6. Hallas J, Gram L, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61-8
7. Cooke DI, Van der Merwe W, Pudifin DJ. Hospital admissions for adverse reactions to drugs and deliberate self-poisoning. S Afr Med J 1985; 67: 770-2
8. Caranasos GJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalisation. JAMA 1974; 228: 713-7
9. Rostin M, Pascaud A, Lauque D, et al. An intensive survey of pharmacovigilance in a medical admission department. Rev Med Interne 1987; 8: 173-9
10. Hallas J, Davidsen F, Grodum E, et al. Drug-related illness as cause of admission to a department of respiratory medicine. Respiration 1992; 59: 30-4
11. Hallas J, Harvald B, Gram LF, et al. Drug related admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83-90
12. Lakshmanan MG, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986; 146: 1931-4
13. Einarson T. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-40
14. Tiberio G, Hueto J, Moreno M, et al. Reacciones adversas medicamentosas: algoritmos de Naranjo y Venulet [in Spanish]. Rev Clin Esp 1992; 191: 270-3
15. Diez JL, Muñoz JL, Castro S. Patologia iatrogenica en un servicio de medicina interna. II. Reacciones adversas a medicamentos [in Spanish]. Med Clin Barc 1986; 87: 131-4
16. Arnau JM, Camps A, Curull V, et al. Programa de detección de reacciones adversas a medicamentos en pacientes hospitalisados. Métodos y resultados de la fase piloto. [in Spanish] Med Clin Barc 1984; 82: 433-7
17. Asscher AW, Parr GD, Whitmarsh VB. Towards the safer use of medicines. BMJ 1995; 311: 1003-5
18. Davies DM. Adverse drug reactions. J Prac Pharm 1987; 5: 127-32
19. Falk RH. Adverse reactions to medication on a coronary care unit. Postgrad Med J 1979; 55: 870-3
20. Trunet P, Le Gall JR, Lhoste F, et al. The role of iatrogenic disease in admissions to intensive care. JAMA 1980; 244: 2617-20
21. Italian Group on Intensive Care Evaluation. Epidemiology of adverse drug reactions in intensive care units. A multicentre prospective survey. Eur J Clin Pharmacol 1987; 31: 507-12
22. Danielson DA, Porter JB, Dinan BJ, et al. Drug monitoring of surgical patients. JAMA 1982; 248: 1482-5
23. Schneider PJ, Gift MG, Lee Y, et al. Cost of medication-related problems at a university hospital. Am J Health-Sys Pharm 1995; 52: 2415-8
24. Moore N, Lecointre D, Noblet C, et al. Serious adverse drug reactions in a Department of Internal Medicine incidence and cost analysis. Pharmacoepidemiol Drug Saf 1995; 5 Suppl. 1: 74
25. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155: 1949-56
26. Böttiger LE, Furhoff AK, Holmberg L. Fatal reactions to drugs. Acta Med Scand 1979; 205: 451-6
27. Caranasos GJ, May FE, Stewart RB, et al. Drug-associated deaths of medical inpatients. Arch Intern Med 1976; 136: 872-5
28. Irey NS. Adverse drug reactions and death. A review of 827 cases. JAMA 1976; 236: 575-8
29. Girdwood RH. Death after taking medicaments. BMJ 1974; 1: 501-4
30. Shapiro S, Slone D, Lewis GP, et al. Fatal drug reactions among medical inpatients. JAMA 1971; 216: 467-72
31. Armstrong B, Dinan B, Jick H. Fatal drug reactions in patients admitted to surgical services. Am J Surg 1976; 132: 643-5
32. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA 1977; 237: 879-81
33. Viñuales A, Napal V, Iruin A, et al. Monitorización intensiva de reacciones adversas medicamentosas en el medio hospitalario: Estudio previo [in Spanish]. Farm Clin 1987; 4: 693-710
34. Davidsen F, Haghfelt T, Gram LF, et al. Adverse drug reactions and drug non-compliance as primary causes of admission to cardiology department. Eur J Clin Pharmacol 1988; 34: 83-6
35. Hallas J, Haghfelt T, Gram LF, et al. Drug related admissions to cardiology department frequency and availability. J Intern Med 1990; 228: 379-84
36. Ostermann G, Labram C, Auloge JP, et al. Bilan de 50 mois de pharmacovigilance intensive dans un service de médecine interne à orientation cardiologique [in French]. Thérapie 1983; 38: 453-60
37. Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975; 234: 1236-41
38. Venulet J. Methods of monitoring adverse reactions to drugs. In: Juscken E, editor. Progress in drug research. Basilea: Berghausen Verlag, 1977: 277-84
39. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45
40. Öreberg M, Jonsson GG, West K, et al. Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors, and socioeconomic differences. Eur J Clin Pharmacol 1992; 43: 449-54
41. Vakil BJ, Kulkarni RD, Chabria NL, et al. Intensive surveillance of adverse drug reactions. J Clin Pharmacol 1975; 15: 435-41
42. Klein U, Klein M, Sturm H, et al. The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalisation. Int J Clin Pharmacol 1976; 13: 187-95
43. Spino M, Sellers EM, Kaplan HL. Effect of adverse drug reactions on the length of hospitalisation. Am J Hosp Pharm 1978; 35: 1060-4
44. Steel K, Gertman PM, Crescenzi C, et al. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med 1981; 301: 638-42
45. Melmon KL. Preventable drug reactions - causes and cures. N Engl J Med 1971; 284: 1361-8
46. Hates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 1995; 24: 29-34